Feds Approve New Vaccine Facility in Bryan-College Station
The federal government has approved a $91 million influenza-vaccine manufacturing facility based in the Bryan-College Station area to be run by the Texas A&M University System and pharmaceutical company GlaxoSmithKline. Full Story